{
  "id": 12703530,
  "title": "Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue",
  "url": "https://urgent.news/2026/10/07/profound-medical-reports-strong-preliminary-third-quarter-2026-revenue",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-07T20:17:01.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/profound-medical-reports-strong-preliminary-third-quarter-2026-revenue"
  },
  "original_language": "en",
  "account": null,
  "summary": "Anticipates Q3-2026 revenue of $9.8 million to $10.0 million, exceeding Bloomberg analyst consensus by approximately 45% to 47% TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, today announced preliminary…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}